Related Experiment Video
Updated: Feb 6, 2026

Author Spotlight: Advancing Understanding Through Technological Innovations in Psychoneuroimmunology
Published on: May 31, 2024
Microglial TREM2/DAP12 Signaling: A Double-Edged Sword in Neural Diseases
Hiroyuki Konishi1, Hiroshi Kiyama1
1Department of Functional Anatomy and Neuroscience, Nagoya University Graduate School of Medicine, Nagoya University, Nagoya, Japan.
Abstract:
Microglia are activated after neuronal injury and in neurodegenerative diseases, and trigger neuroinflammation in the central nervous system (CNS). Microglia-derived neuroinflammation has both beneficial and detrimental effects on neurons. Because the timing and magnitude of microglial activation is thought to be a critical determinant of neuronal fate, understanding the molecular mechanisms underlying microglial activation is required to enable establishment of microglia-targeted therapies for neural diseases. Plasma membrane receptors play primary roles as activators of microglia and in this review, we focus on a receptor complex involving triggering receptor expressed on myeloid cells 2 (TREM2) and DNAX-activating protein of 12 kDa (DAP12), both of which are causative genes for Nasu-Hakola disease, a dementia with bone cysts. Recent transcriptome approaches demonstrated TREM2/DAP12 signaling as the principal regulator that transforms microglia from a homeostatic to a neural disease-associated state. Furthermore, animal model studies revealed critical roles for TREM2/DAP12 in the regulation of microglial activity, including survival, phagocytosis, and cytokine production, not only in Alzheimer's disease but also in other neural diseases, such as Parkinson's disease, demyelinating disease, ischemia, and peripheral nerve injury. Intriguingly, while TREM2/DAP12-mediated microglial activation is detrimental for some diseases, including peripheral nerve injury, it is beneficial for other diseases. As the role of activated microglia differs among disease models, TREM2/DAP12 signaling may result in different outcomes in different diseases. In this review we discuss recent perspectives on the role of TREM2/DAP12 in microglia and their contribution to neural diseases.
Insights
Microglia activation via TREM2/DAP12 signaling shifts their state in neural diseases. This pathway has varied effects, offering potential for targeted therapies in conditions like Alzheimer's and Parkinson's disease.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Microglia, the central nervous system's immune cells, become activated during neuronal injury and neurodegenerative diseases, initiating neuroinflammation.
- Microglial activation, influenced by timing and magnitude, critically determines neuronal fate, necessitating understanding of its molecular mechanisms for targeted therapies.
- Plasma membrane receptors are key activators of microglia; this review focuses on the TREM2/DAP12 receptor complex.
Purpose of the Study:
- To review the role of the TREM2/DAP12 receptor complex in microglial activation.
- To explore how TREM2/DAP12 signaling influences microglial states in various neural diseases.
- To discuss the dual beneficial and detrimental roles of TREM2/DAP12-mediated microglial activation across different disease contexts.
Main Methods:
- Review of recent transcriptome approaches identifying TREM2/DAP12 signaling.
- Analysis of animal model studies investigating TREM2/DAP12 functions in neural diseases.
- Synthesis of current research on TREM2/DAP12's impact on microglial survival, phagocytosis, and cytokine production.
Main Results:
- TREM2/DAP12 signaling is identified as a principal regulator transforming microglia from a homeostatic to a disease-associated state.
- TREM2/DAP12 plays critical roles in microglial activity regulation across diverse neural conditions, including Alzheimer's, Parkinson's, and peripheral nerve injury.
- The outcomes of TREM2/DAP12-mediated microglial activation can be either detrimental or beneficial, depending on the specific disease context.
Conclusions:
- TREM2/DAP12 signaling is a central mechanism in microglial responses to neural injury and disease.
- Understanding the context-dependent roles of TREM2/DAP12 is crucial for developing effective microglia-targeted therapies.
- Further research into TREM2/DAP12 pathways may unlock new therapeutic strategies for a range of neurological disorders.
Related Concept Videos
Fixing Double-strand Breaks
Fixing Double-strand Breaks
Neural Regulation
Endocrine Signaling
Bacterial Signaling
Yeast Signaling

